Streetbeat News

Analyst Ratings

RLAY

JMP Securities analyst Silvan Tuerkcan has reiterated a Market Outperform rating for Relay Therapeutics (NASDAQ:RLAY) and maintained a price target of $21.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 4:14 pm

RYTM

JMP Securities has initiated coverage on Rhythm Pharmaceuticals with a Market Outperform rating and set a price target of $64.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 4:11 pm

ACVA

JMP Securities analyst Nicholas Jones has maintained a Market Outperform rating on ACV Auctions and raised the price target from $21 to $24.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 4:05 pm

AMZN

AVGO

INTC

TSM

Intel's stock rose after announcing a multi-billion-dollar deal with AWS and receiving a U.S. semiconductor grant. Analysts have mixed views, with BofA Securities maintaining an Underperform rating, Northland Capital Markets giving an Outperform rating, and KeyBanc Capital Markets reaffirming a Sector Weight rating.

Portfolio Pulse from Priya Nigam

September 17, 2024 | 4:01 pm

FIHL

Fidelis Insurance Hldgs (NYSE:FIHL) has received mixed analyst ratings, with a current average price target of $21.08, down from $22.17. Analysts have varied opinions, ranging from 'Neutral' to 'Outperform'. The company shows strong revenue growth and net margin but lags in ROE and ROA.

Portfolio Pulse from Benzinga Insights

September 17, 2024 | 4:00 pm

O

Realty Income (NYSE:O) has received mixed ratings from 11 analysts, with a majority being indifferent. Recent analyst actions show raised price targets, indicating a positive outlook. The average 12-month price target is $64.34, up 6.74% from the previous target. Despite strong revenue growth, Realty Income faces challenges with net margin, ROE, and ROA, but maintains a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

September 17, 2024 | 4:00 pm

OZK

Analysts have varied ratings for Bank OZK, with recent evaluations showing a mix of 'Equal-Weight' and 'Hold' ratings. The average 12-month price target has increased to $47.75. Bank OZK has shown strong financial performance with impressive revenue growth, net margin, and return on equity.

Portfolio Pulse from Benzinga Insights

September 17, 2024 | 4:00 pm

PB

Prosperity Bancshares (NYSE:PB) has received diverse analyst ratings over the past three months, with a majority being bullish. The average 12-month price target has increased to $78.44, indicating positive sentiment. The company has shown strong revenue growth and net margin, but faces challenges with ROE and debt management.

Portfolio Pulse from Benzinga Insights

September 17, 2024 | 4:00 pm

TGLS

Analysts have mixed ratings for Tecnoglass (NYSE:TGLS), with recent price target increases indicating optimism. The average 12-month price target is $67.2, up 12.94% from the previous $59.50. Despite revenue challenges, Tecnoglass shows strong net margins and efficient asset use.

Portfolio Pulse from Benzinga Insights

September 17, 2024 | 4:00 pm

NEM

Analysts have provided mixed ratings for Newmont (NYSE:NEM) over the past three months, with a majority being bullish. The average 12-month price target has increased by 15.81% to $57.71. Recent analyst actions include several upgrades and increased price targets, reflecting positive sentiment towards Newmont's market performance and financial health.

Portfolio Pulse from Benzinga Insights

September 17, 2024 | 4:00 pm